Cardiac troponin I (cTnI) is a highly sensitive and specific biomarker widely used in clinical practice for the diagnosis, risk stratification, and prognosis of acute myocardial infarction (AMI) in humans [12]. The gene discussed is TNNI3; the disease is myocardial infarction.